Georg Kääb's articles Biotechnology Tubulis secures €308m in record-breaking Series C financing Munich-based biotech Tubulis has closed a €308m (US$361m) Series C financing round – the largest of its kind for a European biotechnology company at the Series C stage and also the world’s largest financing for a private ADC (antibody–drug conjugate) developer. The round was led by Venrock Healthcare Capital Partners, joined by new investors Wellington […] Written by Georg Kääb October 16, 2025October 16, 2025 Saving Bookmark this article Bookmarked Biotechnology From Brisbane to London to Paris: Vicebio´s Sanofi deal What began in the labs of the University of Queensland has now set the stage for one of Europe’s largest biotech acquisitions of the year. Sanofi has announced it will acquire UK-based vaccine developer Vicebio for $1.15 billion upfront, with an additional $450 million tied to clinical milestones—underscoring a major commitment to next-generation respiratory vaccines. […] Written by Georg Kääb July 24, 2025July 24, 2025 Saving Bookmark this article Bookmarked Biotechnology Cradle Secures $73m Series B to Accelerate AI-Driven Protein Engineering Cradle, the pioneering platform for AI-powered protein engineering in Amsterdam, Netherlands, has successfully raised US$73m in Series B funding. The round, led by IVP with participation from existing investors Index Ventures and Kindred Capital, brings the company’s total funding to over US$100m. Cradle’s generative AI platform is already used across multiple industries, including pharmaceuticals, agriculture, […] Written by Georg Kääb November 30, 2024November 30, 2024 Saving Bookmark this article Bookmarked
Biotechnology Tubulis secures €308m in record-breaking Series C financing Munich-based biotech Tubulis has closed a €308m (US$361m) Series C financing round – the largest of its kind for a European biotechnology company at the Series C stage and also the world’s largest financing for a private ADC (antibody–drug conjugate) developer. The round was led by Venrock Healthcare Capital Partners, joined by new investors Wellington […] Written by Georg Kääb October 16, 2025October 16, 2025 Saving Bookmark this article Bookmarked
Biotechnology From Brisbane to London to Paris: Vicebio´s Sanofi deal What began in the labs of the University of Queensland has now set the stage for one of Europe’s largest biotech acquisitions of the year. Sanofi has announced it will acquire UK-based vaccine developer Vicebio for $1.15 billion upfront, with an additional $450 million tied to clinical milestones—underscoring a major commitment to next-generation respiratory vaccines. […] Written by Georg Kääb July 24, 2025July 24, 2025 Saving Bookmark this article Bookmarked
Biotechnology Cradle Secures $73m Series B to Accelerate AI-Driven Protein Engineering Cradle, the pioneering platform for AI-powered protein engineering in Amsterdam, Netherlands, has successfully raised US$73m in Series B funding. The round, led by IVP with participation from existing investors Index Ventures and Kindred Capital, brings the company’s total funding to over US$100m. Cradle’s generative AI platform is already used across multiple industries, including pharmaceuticals, agriculture, […] Written by Georg Kääb November 30, 2024November 30, 2024 Saving Bookmark this article Bookmarked
